A Trial of Bardoxolone Methyl in Patients With ADPKD – FALCON

A Trial of Bardoxolone Methyl in Patients With ADPKD – FALCON

Conditions:   Autosomal Dominant Polycystic Kidney;   ADPKD
Interventions:   Drug: Bardoxolone methyl oral capsule;   Drug: Placebo oral capsule
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffADPKD | Bardoxolone | FALCON | Methyl | Patients | Trial
Comments